article thumbnail

CVD and obesity: When protective lipids decline, health risks increase

Science Daily - Heart Disease

New research has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes -- not the presence of certain fats, but their suppression. Ironically, the findings could ultimately lead to therapies that maintain high levels of these protective lipids in patients with obesity.

Obesity 66
article thumbnail

Population shifts, risk factors may triple U.S. cardiovascular disease costs by 2050

Science Daily - Heart Disease

Driven by an older, more diverse population, along with a significant increase in risk factors including high blood pressure and obesity, total costs related to cardiovascular disease (CVD) conditions are likely to triple by 2050, according to recent projections. At least 6 in 10 U.S.

article thumbnail

Men at high risk of cardiovascular disease face brain health decline 10 years earlier than women, study finds

Medical Xpress - Cardiology

Men with cardiovascular disease risk factors, including obesity, face brain health decline a decade earlier—from their mid 50s to mid 70s—than similarly affected women who are most susceptible from their mid 60s to mid 70s, suggest the findings of a long term study, published online in the Journal of Neurology Neurosurgery & Psychiatry.

article thumbnail

Effects of weight loss after sleeve gastrectomy on left ventricular myocardial work in obese patients

Frontiers in Cardiovascular Medicine

BackgroundObesity is a global epidemic and a major risk factor for cardiovascular diseases. This study aims to investigate the impact of weight loss after LSG on the left ventricular myocardial work (LVMW) in obese patients and explore the clinical value of the left ventricular pressure - strain loop (LV - PSL).MethodsThirty

Obesity 52
article thumbnail

Population shifts, risk factors may triple U.S. cardiovascular disease costs by 2050

American Heart News - Heart News

ET Tuesday, June 4, 2024 DALLAS, June 4, 2024 — Driven by an older, more diverse population, along with a significant increase in risk factors including high blood pressure and obesity, total costs related to.

article thumbnail

Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes

Cardiovascular Diabetology

Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovascular disease. During the 4.22-year

Obesity 98
article thumbnail

Cholesterol is not the only lipid involved in trans fat-driven cardiovascular disease

Science Daily - Heart Disease

This new insight into the flow of fats through the body points to new therapeutic targets for mitigating diseases like ASCVD, non-alcoholic fatty liver disease, obesity, diabetes, peripheral neuropathy, and neurodegeneration.